Medical Weight Loss for Schenectady, New York Residents
Schenectady, New York residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Schenectady through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Schenectady Residents Choose New Hope Weight Loss
Since 2020, New Hope Weight Loss has treated more than 5,400 patients from its Costa Mesa, California clinic, and Schenectady, New York residents get that same physician-led program by telehealth. Pricing is flat and transparent, with care overseen by Dr. Anjmun Sharma, M.D., and no insurance required to start.
Medical weight loss for Schenectady is handled end-to-end online: intake, the $119 physician review with Dr. Sharma, dose titration, and follow-ups, all by secure video, with no drive and no pharmacy line.
Although our clinic is physically in Costa Mesa, California, Schenectady residents receive the same physician-supervised care without leaving New York. We care for patients throughout the greater Schenectady area and the Capital Region. Whether you are starting your first GLP-1 program or switching from a brand medication, your Schenectady treatment plan is built around your health history and goals.
For Schenectady residents, being seen by video means starting this week instead of waiting for an in-person appointment. Compounded medication arrives in discreet, cold-pack packaging at your Schenectady address, usually within days.
GLP-1 Weight Loss Programs Available
Semaglutide (90-Day Metabolic Reset), from $166/mo
Our most popular program for Schenectady patients uses semaglutide, the same active ingredient found in Wegovy® and Ozempic®. In clinical trials of the branded drug, patients lost an average of 15-17% of body weight, with physician oversight and monthly dose adjustments.
Tirzepatide (Advanced Program), from $233/mo · just $7.70/day
For maximum results, tirzepatide uses a dual GLP-1/GIP mechanism that clinical trials showed can reach up to 22.5% body-weight loss.
Doctor review: $119. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted.
How Telehealth Works for Schenectady
First, you complete the online medical intake in a few minutes. Next, Dr. Sharma reviews your history by secure video, usually within 48 hours. If you are a candidate and telehealth-eligible, your compounded medication ships to your Schenectady address in cold-pack packaging, and follow-ups and dose adjustments continue by video, with no travel.
Frequently Asked Questions, Schenectady
How do I get treatment from Schenectady?
As a Schenectady, New York patient you connect with our Costa Mesa, California clinic by telehealth. Dr. Sharma oversees your plan by secure video and compounded medication ships to your home; eligibility is confirmed during the consultation.
Can I do this without an in-person visit from Schenectady?
Yes, it is fully telehealth. Your review, prescription, and follow-up are remote, with medication shipped to Schenectady in cold-pack packaging, no lines and no drive.
How much does it cost for Schenectady patients?
A $119 physician review, then compounded semaglutide from $166/month or tirzepatide from $233/month (medication separate). HSA, FSA, Klarna, and Affirm are accepted, and there is never a distance surcharge.
What areas of Schenectady do you serve?
We serve patients from across Schenectady by telehealth, including the greater Schenectady area and the Capital Region.
How is medication shipped to Schenectady patients?
After Dr. Sharma approves your plan, compounded medication ships in discreet, temperature-appropriate packaging directly to your Schenectady address from the identified 503(a) compounding pharmacy. Most patients receive it within days, with no pharmacy line and no drive.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Schenectady, New York by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.